MX2007005336A - Analgesicos. - Google Patents

Analgesicos.

Info

Publication number
MX2007005336A
MX2007005336A MX2007005336A MX2007005336A MX2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A
Authority
MX
Mexico
Prior art keywords
analgesic
various
compound
active ingredient
acid addition
Prior art date
Application number
MX2007005336A
Other languages
English (en)
Spanish (es)
Inventor
Hiroshi Nagabukuro
Tadatoshi Hashimoto
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of MX2007005336A publication Critical patent/MX2007005336A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007005336A 2004-11-04 2005-11-04 Analgesicos. MX2007005336A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04
PCT/JP2005/020297 WO2006049248A1 (ja) 2004-11-04 2005-11-04 鎮痛剤

Publications (1)

Publication Number Publication Date
MX2007005336A true MX2007005336A (es) 2007-06-25

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005336A MX2007005336A (es) 2004-11-04 2005-11-04 Analgesicos.

Country Status (12)

Country Link
US (1) US8470845B2 (enExample)
EP (1) EP1820505A4 (enExample)
JP (1) JP4706636B2 (enExample)
KR (1) KR101285645B1 (enExample)
CN (1) CN101090722B (enExample)
AR (1) AR053098A1 (enExample)
CA (1) CA2586181C (enExample)
MX (1) MX2007005336A (enExample)
NO (1) NO20072832L (enExample)
PE (1) PE20060723A1 (enExample)
TW (1) TW200621785A (enExample)
WO (1) WO2006049248A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055184A1 (ja) * 2005-11-09 2007-05-18 Toray Industries, Inc. 機能性腸障害の治療または予防剤
WO2007072749A1 (ja) * 2005-12-21 2007-06-28 Toray Industries, Inc. 鎮咳剤
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
AU2008254038B2 (en) * 2007-05-21 2013-01-10 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
ES2627217T3 (es) * 2007-05-21 2017-07-27 Toray Industries, Inc. Partículas micropulverizadas cristalinas
AU2008254039B2 (en) * 2007-05-21 2013-10-24 Toray Industries, Inc. Method for producing pharmaceutical tablet
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
DK3761982T3 (da) 2018-03-08 2025-01-02 Victoria Link Ltd Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (enExample) * 1964-02-03 1966-10-31
US3318884A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6-demethoxythebaine and 6-amino-6-demethoxyoripavine derivatives
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
AU5090796A (en) * 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
AU6020300A (en) * 1999-07-19 2001-02-05 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
JP4340437B2 (ja) 2000-10-31 2009-10-07 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
BR0314754A (pt) * 2002-10-09 2005-07-26 Toray Industries Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
TW200533355A (en) 2004-03-30 2005-10-16 Toray Industries Antipruritic agent

Also Published As

Publication number Publication date
HK1115808A1 (en) 2008-12-12
CA2586181C (en) 2012-11-27
US20070299100A1 (en) 2007-12-27
KR20070085436A (ko) 2007-08-27
CA2586181A1 (en) 2006-05-11
TW200621785A (en) 2006-07-01
WO2006049248A1 (ja) 2006-05-11
TWI356826B (enExample) 2012-01-21
US8470845B2 (en) 2013-06-25
PE20060723A1 (es) 2006-08-29
CN101090722B (zh) 2011-12-21
CN101090722A (zh) 2007-12-19
NO20072832L (no) 2007-08-01
AR053098A1 (es) 2007-04-25
EP1820505A1 (en) 2007-08-22
JP4706636B2 (ja) 2011-06-22
KR101285645B1 (ko) 2013-07-12
EP1820505A4 (en) 2010-01-20
JPWO2006049248A1 (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
MY147211A (en) Novel dihydropseudoerythromycin derivatives
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
TW200615266A (en) Organic compounds
WO2009060835A1 (ja) 新規ユビキリン結合性小分子
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
TNSN08407A1 (en) Organic compounds
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
WO2004056827A3 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
TW200744588A (en) Pharmaceutical composition for external use
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
TW200728307A (en) Novel spirochromanone derivatives
TW200714583A (en) Substituted gamma lactams as therapeutic agents
TW200612958A (en) Substituted imidazole derivatives
MX2009013730A (es) Compuesto amina y uso farmaceutico del mismo.
WO2007146856A3 (en) Substituted gamma lactams as therapeutic agents
WO2008139845A8 (ja) 新規アミド誘導体
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
MX2007005336A (es) Analgesicos.
WO2005092304A3 (en) Antifungal agents
MX2009001578A (es) Lactamas terapeuticas.
WO2007005941A3 (en) Liver targeted conjugates
GB0212410D0 (en) Organic compounds
EP1219296A4 (en) MEANS TO INHIBIT SEBUM PRODUCTION
TW200733963A (en) Cough inhibitor

Legal Events

Date Code Title Description
FG Grant or registration